Logo

OncoDNA

OncoDNA, Institut Jules Bordet Partner on Central Nervous System Metastasis Study

OncoDNA will use its sequencing panels to detect circulating tumor DNA in cerebrospinal fluid samples from patients diagnosed with solid tumors.

OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer

The French cancer center will use OncoDNA's blood-based next-generation sequencing test, OncoFollow, in its ongoing SCANDARE study.

OncoDNA, myNEO Partner to Advance Bespoke mRNA-Based Cancer Vaccines

The two firms will use their sequencing and informatics technologies to develop personalized cancer vaccines targeting patients' unique neoantigens.

Belgian Society of Medical Oncology to Study Value of Genomic Profiling for Cancer Patients

The Belgian Society of Medical Oncology has partnered with Illumina, OncoDNA, and PierianDx for this study, which will enroll 864 patients with advanced metastatic cancer.

OncoDNA Inks Contract With HalioDx to Expand Pharma Testing Services Into North America

HalioDx operates a CLIA-certified lab through which OncoDNA will provide it molecular testing services to drugmakers studying precision cancer therapies.

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.